FDA hosts the Centers of Excellence in Regulatory Science and Innovation (CERSI) program to foster robust and innovative approaches to advance regulatory science, and the goal is for the CERSIs to advance regulatory science individually and synergistically, under the CERSI Program led by the Office of Regulatory Science and Innovation (ORSI), through collaborative interactions with FDA scientific experts and funding offices.
The CERSIs promote innovation in regulatory science predominantly through cutting-edge scientific research that supports FDA's regulatory science needs. They may also provide regulatory science information sharing opportunities, such as lectures, workshops, courses, scholar awards, fellowships, and competitions.
FDA currently has cooperative agreements with the University of Maryland, University of California at San Francisco (UCSF) in a joint effort with Stanford University (UCSF-Stanford), Johns Hopkins University, and Yale University in joint effort with Mayo Clinic.
FDA is seeking applications for Centers of Excellence in Regulatory Science and Innovation (CERSIs), to conduct collaborative regulatory science research and foster information sharing. Letters of intent are due by October 31, 2022, and applications are due by December 22, 2022.
FDA has developed Outcomes of Interest for Regulatory Science Research Projects. which will be used to assess the contributions/impact of the CERSI program.
CERSI Regulatory Science Information Sharing Opportunities
- Workshops and Training Courses
- Lectures and Webinars
- Scholars Program
- America's Got Regulatory Science Talent Competition